Contract award · W81XWH20F0253
COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION
Awarded to INBIOS INTERNATIONAL, INC · CAGE 3KJL6
Latest reported total obligated
Not reported
Net observed obligations
$24.5M
Observed contract actions
18
Observed period
FY2020–FY2026
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorINBIOS INTERNATIONAL, INC
CAGE3KJL6
CustomerDefense Health Agency
Performance locationSEATTLE, WASHINGTON, UNITED STATES
Procurement details
First observed actionJun 11, 2020
Latest observed actionMar 10, 2026
PSCAJ53
NAICS541711
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingCOST PLUS FIXED FEE
SolicitationW81XWH15R0014
Annual observed obligations
FY2020
$2.5M
FY2021
$14.1M
FY2022
$9.1M
FY2026
-$1.1M
Continue exploring
Ask Mimir about W81XWH20F0253
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.